Abstract-Background: Elevated plasma total homocysteine (tHcy) concentrations are associated with AD and vascular dementia, but the relation with cognitive performance in nondemented elderly people is not known. Objective: To examine the association of tHcy and cognitive function in the elderly, and assess whether this may be mediated by structural brain changes on MRI. Methods: The Rotterdam Scan Study is a population-based study of 1,077 nondemented elderly. Cognitive performance was assessed, and compound scores were constructed for psychomotor speed, memory function, and global cognitive function. Cerebral infarcts, white matter lesions, and generalized brain atrophy were measured on MRI. The cross-sectional relationship between tHcy levels and neuropsychological test scores was assessed by multiple regression. Results: Mean tHcy level was 11.5 mol/L (SD 4.1). Increasing tHcy levels were associated with lower scores for psychomotor speed, memory function, and global cognitive function, and this was largely due to the association with tHcy levels in the upper quintile (Ͼ14 mol/L). Adjusted differences between test scores of participants in the upper quintile as compared with the lower four quintiles of tHcy were Ϫ0.26 (95% CI: Ϫ0.37; Ϫ0.14) for psychomotor speed, Ϫ0.13 (95% CI: Ϫ0.27; 0.01) for memory function, and Ϫ0.20 (95% CI: Ϫ0.30; Ϫ0.11) for global cognitive function. These associations were not mediated by structural brain changes on MRI. Conclusion: Elevated tHcy levels are associated with decreased cognitive performance in nondemented elderly people, and the relation was most marked for psychomotor speed. This association was independent of structural brain changes on MRI.
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Homocysteine is a sulfur-containing amino acid derived from methionine. Plasma total homocysteine (tHcy) concentrations are increased in patients with AD and vascular dementia. 1, 2 In a large longitudinal study, increased tHcy was a risk factor for the development of dementia and AD. 3 Previous studies in nondemented elderly have reported that higher tHcy levels are associated with worse cognitive performance [4] [5] [6] and with cognitive decline, 7 but many of these studies have been small or the instruments used to measure cognitive function were unspecific to assess these associations reliably.
The adverse effects of tHcy on cognitive function may arise as a consequence of direct neurotoxicity 8 or indirectly through cerebrovascular disease. 9 The relevance of structural brain changes as assessed by MRI, such as cerebral infarcts, white matter lesions (WML), and generalized brain atrophy, as possible intermediates in the association of tHcy with cognitive function has not been previously studied.
We investigated the relation between elevated tHcy levels and cognitive performance in a nondemented elderly population and assessed the extent to which any association may be mediated by structural brain changes on cerebral MRI.
Subjects and methods. Subjects. The Rotterdam Scan
Study was designed to study the causes and consequences of age-related brain changes in the elderly. 10 Participants were recruited from the Rotterdam Study 11 and the Zoetermeer Study, 12 which are ongoing prospective cohort studies. In 1995 through 1996, 1,904 elderly aged 60 to 90 years were randomly selected after stratification by sex and by age in 5-year age groups. Among the invited subjects, 187 were excluded (owing to presence of dementia, a contraindication for MRI scanning, or blindness). Assessment of dementia was performed by using a stepped approach. All participants were initially screened with the Mini-Mental State Examination (MMSE) 13 and the Geriatric Mental Schedule (GMS), organic section.
14 Subsequently, participants who scored below a cutoff of 26 on the MMSE or above 0 on the GMS were further evaluated using more extensive neuropsychological tests, including an informant interview, and review of medical records. Of the 1,717 eligible participants, 1,077 completed all examinations (overall response 63%). Each participant gave informed consent to protocol, which was approved by the medical ethics committee of the Erasmus Medical Center, Rotterdam.
Total plasma homocysteine level. We collected nonfasting blood samples from participants into Vacutainers (Becton-Dickinson, Oxford, UK) containing sodium citrate in 1995 through 1996; these whole blood samples were put on ice immediately and centrifuged within 60 minutes, and aliquots of plasma were stored at Ϫ80°C. Plasma total tHcy concentrations were determined, 3 years after storage, by fluorescence polarization immunoassay on an IMx analyzer (Abbott Laboratories, Chicago, IL). This method has an intralaboratory imprecision of less than 5%. 15 Blood samples were unavailable for tHcy measurement in 39 participants, either owing to inability to collect the blood sample or loss of samples after collection. Seven participants whose tHcy levels were greater than 45 mol/L were excluded.
Neuropsychological testing. Neuropsychological tests were administered in 1995 through 1996. We used the following three tests to assess executive function: an abbreviated Stroop test, 16, 17 the Letter-Digit Substitution Task (a modified version of the Symbol Digit Modalities Test), 18 and a verbal fluency test. 19 A Paper-and-Pencil Memory Scanning Task consisting of four subtasks was used to measure attention. 20, 21 We assessed memory function by means of a 15-word verbal learning test (based on Rey's recall of words), 22 which consists of three immediate recall trials and a delayed recall of words. An average or compound cognitive test score was made by transforming individual test scores into standardized Z-scores (Z-score ϭ test score Ϫ mean test score/SD). Compound scores were estimated for psychomotor speed, memory performance, and global cognitive function. 23 Compound scores for psychomotor speed were calculated by averaging the Z-scores of the reading subtask of the Stroop test, the one letter subtask of the Paper-and-Pencil Memory Scanning Test, and the Letter-Digit Substitution Task. Compound scores for memory function were calculated by averaging the Z-scores of the total of three immediate recall trials and the delayed recall trial of the 15-word verbal learning tests. Compound scores for global cognitive performance were calculated by averaging the Z-scores of the reading subtask of the Stroop test, the one letter subtask of the Paper-and-Pencil Memory Scanning Test, the Letter-Digit Substitution Task, and the immediate and delayed recall of the 15-word verbal learning test. The MMSE 13 was used as a general indicator of cognitive function.
MRI procedure. Cranial MRI scanning was performed in all participants with 1.5-Tesla scanners at two centers to assess the presence of cerebral infarcts, WML, and generalized brain atrophy, as previously published. 23, 24 Cerebral infarcts were defined as focal hyperintensities on T2-weighted images, 3 mm or larger. Lesions in the white matter also had to have corresponding prominent hypointensities on T1-weighted images. WML were considered present if visible as hyperintense on proton density and T2-weighted images, without prominent hypointensity on T1-weighted images. WML were scored for periventricular and subcortical areas, resulting in a total periventricular score (range 0 to 9) and an index for total subcortical WML volume (range 0 to 29.5). Generalized brain atrophy was scored on T1-weighted images. Subcortical atrophy was measured by the ventricle-to-brain ratio (range 0.21 to 0.45) and cortical atrophy was rated on a semiquantitative scale (range 0 to 15) using reference scans.
Duplex ultrasonography. Both the right and left carotid arteries were examined for the presence of plaques in the common carotid artery, the bifurcation, and the internal carotid artery using a 7.5 MHz linear array transducer and a Duplex scanner (ATL Ultra-Mark IV, Advanced Technology Laboratories, Bethel, WA). 25 Plaques per region were defined as being present or absent, and the data were used to estimate a carotid plaque score of 0 to 6.
Other measurements. The following variables were considered as possible confounding variables in the relationship between tHcy and cognition: age, sex, the highest level of education achieved (according to the United Nations Educational, Scientific, and Cultural Organization [UNESCO]), 26 disturbances of mood (determined with the Center of Epidemiologic Studies Depression Scale [CES-D]), 27 serum creatinine level (enzymatic assay), 28 and use of cigarettes (pack-years) and alcohol (units/day).
Data analysis. Among the 1,077 study participants, 1,031 had tHcy levels within the reliable 5 to 45 mol/L range. All neuropsychological data were missing in four participants. Of the remaining 1,027, data on one or more tests were incidentally missing or incomplete due to physical handicap, insufficient motivation, or technical problems. The association of tHcy level with cognitive performance, as assessed using neuropsychological test scores, was assessed using multivariate linear regression, treating tHcy as a continuous variable. To assess whether the relationship between tHcy and cognitive performance was linear, we analyzed this relationship using tHcy categorized into quintiles of its distribution. Limits in tHcy level for the different quintiles were as follows: first quin- tile increasing tHcy, participants had more WML, more cerebral infarcts, and more cortical atrophy, after adjustment for age and sex. 29 The figure shows the relationship between tHcy in quintiles and compound scores for psychomotor speed, memory function, and global cognitive function, adjusted for age, sex, education, depression, and serum creatinine. There was an apparent threshold in the relation of cognitive performance between the lowest four quintiles and the upper quintile (Ͼ14.0 mol/L) of tHcy. The association of tHcy and test scores for individual neuropsychological tests showed a similar pattern. We therefore performed subsequent analyses with tHcy dichotomized into the top quintile and the lower four quintiles. Table 2 shows the relation between neuropsychological tests and tHcy level dichotomized at the upper quintile (Ͼ14.0 mol/L) compared with the lower four quintiles. Individuals with elevated tHcy levels in the upper quintile had worse performance on all individual neuropsychological tests, although this difference in test performance was not significant for the MMSE, the three-letter subtask of the Paperand-Pencil Memory Scanning Test, and the immediate and delayed recall of the 15-word verbal learning test. Further adjustment for use of alcohol and for smoking did not alter these associations (data not shown). Table 3 shows the relation between tHcy and neuropsychological compound scores after further adjustment for cerebral infarcts, WML, and generalized brain atrophy. The difference in neuropsychological compound scores between people with tHcy levels in the upper quintile compared to the lower four quintiles was only slightly attenuated after adjustment for these radiologic variables. Furthermore, the relation of tHcy with cognitive performance was unaltered by further adjustment for carotid artery plaques (data not shown). Discussion. Elevated plasma tHcy levels were significantly associated with adverse cognitive function in this large population-based study of elderly people. The associations of tHcy were strongest for psychomotor speed, but were also present for memory function. There was an apparent threshold for tHcy of about 14 mol/L, above which it was significantly associated with adverse cognitive performance. This association of tHcy with cognitive function appeared to be independent of the presence of cerebral infarcts, WML, or generalized brain atrophy on MRI.
Figure. Relation between plasma total homocysteine (tHcy) in quintiles and cognitive function (expressed as mean
Using a cross-sectional study design for these analyses, the current report cannot refute the possibility that high tHcy levels were a consequence of cognitive impairment rather than being causally related to cognitive impairment. It is possible that dementia can lead to a deterioration of diet, resulting in insufficient intake of folate and vitamin B 12 and elevated tHcy levels. Because people with dementia were excluded from our study, we consider it unlikely that cognitive dysfunction may have caused elevation in tHcy levels. A large follow-up study found that increased tHcy levels were strongly and independently related to the development of dementia and AD, 3 suggesting that high tHcy levels may be causally related, rather than being a consequence of impaired cognitive function.
The use of a single tHcy measurement to classify persons may have underestimated the strength of any associations due to regression dilution by 15 to Values are adjusted mean differences in compound score between the highest quintile (Ͼ14.0 mol/L) of total plasma homocysteine (tHcy) and the lower four quintiles and 95% CI.
* Adjusted for age, sex, education, depression, and serum creatinine. † Additional to model 1.
30%. 30 Furthermore, we could not assess the relative importance of vitamin status (such as vitamin B 12 and folate) or free thyroxine levels for cognitive function.
The overall response rate to invitation to participate in this study was 63%. Nonparticipants were older and had a higher frequency of hypertension, and had lower MMSE scores than participants. 23 Consequently, the proportion of people with cognitive impairment may have been underestimated in our study. However, we have no reason to believe that the association of tHcy with cognitive function may be materially different between participants and nonparticipants.
The results of the current analyses confirm the findings suggested by the results of previous studies on the association of high tHcy levels with cognitive dysfunction and dementia. [1] [2] [3] [4] [5] [6] We found a threshold effect in the relation between tHcy and cognitive function above tHcy levels of 14 mol/L. 31 The possibility that tHcy levels under 14 mol/L may affect cognitive function cannot be excluded, but the extent that this occurs remains below threshold of detection using the neuropsychological tests used in this report. We found that participants with high tHcy levels tended to have lower MMSE scores, although this association was not significant. We previously reported a lack of association between tHcy and cognitive impairment (defined as a MMSE score of 25 or lower) and cognitive decline (defined as a drop in MMSE of more than one point per year) in a random sample of participants from the Rotterdam study. 32 These findings may be explained by a low sensitivity of the MMSE to detect subtle differences in cognitive function in healthy elderly populations, and a short follow-up period with a mean of 2.7 years. Another study with a longer follow-up and older subjects did find a significant association between tHcy and decline in MMSE. 7 There are several plausible biological mechanisms that may explain the relationship between tHcy levels and cognitive function. Elevated tHcy is an independent risk factor for cerebrovascular disease, 33 which in turn is a risk factor for cognitive decline and dementia. 34 We recently reported on the association of tHcy and silent brain infarcts and WML in the Rotterdam Scan Study. 29 Previously we reported on the association of WML and cognitive function. 23 In the current study we found that the association between tHcy and cognitive function was not mediated by cerebral infarcts, WML, or generalized brain atrophy. Although we cannot exclude that measurement error involved in the assessment of structural brain changes was associated with a failure to establish such an intermediate role, we suggest that other mechanisms play a role in the association of tHcy and cognitive function. tHcy may have a direct neurotoxic effect. 8 Additionally, high tHcy levels may be a marker of impaired methylation reactions in brain tissue, which play an important role in the production of neurotransmitters, phospholipids, and myelin. 35 Finally, high tHcy may promote ␤-amyloidpeptide mediated toxic effects on neuronal cells. 36 Further prospective and intervention studies are needed to confirm whether the association between high tHcy levels and cognitive dysfunction is causal, and whether lowering of the plasma tHcy level reduces the risk of cognitive decline and dementia.
